Not finding it? Sign in to also search OpenAlex live.
-
Activating mutations in JAK2 and CALR differentially affect intracellular calcium flux in store operated calcium entry2024 Cell Communication and Signaling article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Vikas Bhuria, Tobias J. Franz, Conny K. Baldauf, Martin Böttcher, Nicolas Chatain, Steffen Koschmieder, +5 more
18citations -
The JAK2V617F and CALR mutations and risk of cancer, cardiovascular diseases, and all‐cause mortality2025 Journal of Internal Medicine article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Morten Kranker Larsen, Vibe Skov, Lasse Kjær, Christina Schjellerup Eickhardt‐Dalbøge, Trine Alma Knudsen, Marie Hvelplund Kristiansen, +11 more
15citations -
Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT2023 Research Square preprint Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Juan Carlos Hernández‐Boluda, Diderik-Jan Eikema, Linda Köster, Nicolaus Martin Kröger, Marie Robin, Moniek A. de Witte, +20 more
1citations -
The telomerase inhibitor imetelstat differentially targets JAK2V617F versus CALR mutant myeloproliferative neoplasm cells and inhibits JAK-STAT signaling2023 Frontiers in Oncology article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Kathrin Olschok, Bianca Altenburg, Marcelo A. S. Toledo, Angela Maurer, Anne Abels, Fabian Beier, +7 more
15citations -
CALR frameshift mutations in MPN patient-derived iPS cells accelerate maturation of megakaryocytes2021 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Kathrin Olschok, Lijuan Han, Marcelo A. S. Toledo, Janik Böhnke, Martin Graßhoff, Ivan G. Costa, +14 more
0citations -
CALR frameshift mutations in MPN patient-derived iPSCs accelerate maturation of megakaryocytes2021 Stem Cell Reports article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Kathrin Olschok, Lijuan Han, Marcelo A. S. Toledo, Janik Böhnke, Martin Graßhoff, Ivan G. Costa, +14 more
25citations -
Case Report: First longitudinal study of a patient with CALR positive clonal hematopoiesis of indeterminate potential developing into pre-fibrotic myelofibrosis2023 Frontiers in Oncology article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Lasse Kjær, Vibe Skov, Morten Kranker Larsen, Tobias Idor Boklund, Morten Andersen, Maria Alexandra Kefala, +9 more
5citations -
Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT2023 Bone Marrow Transplantation article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Juan Carlos Hernández‐Boluda, Diderik-Jan Eikema, Linda Köster, Nicolaus Martin Kröger, Marie Robin, Moniek A. de Witte, +20 more
9citations -
Selective dependency of CALR-mutant myeloproliferative neoplasms on TYK2 signaling2026 Research Square preprint Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Milena Kalmer, Chiara Wirths, Rebecca Lemanzyk, Alessia Piergentili, Bärbel Junge, Jonas Goßen, +13 more
1citations -
Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR-Mutant Chronic Myeloproliferative Neoplasms2021 Frontiers in Oncology article Immunology and Microbiology Immunotherapy and Immune Responses Open access cited by 1 patent
Jacob Handlos Grauslund, Morten Orebo Holmström, Nicolai Grønne Dahlager Jørgensen, Uffe Klausen, Stine Emilie Weis-Banke, Daniel El Fassi, +16 more
59citations -
DNA methylation in primary myelofibrosis is partly associated with driver mutations and distinct from other myeloid malignancies2025 Clinical Epigenetics article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Esra Dursun Torlak, Vithurithra Tharmapalan, Kim Kricheldorf, Joelle Schifflers, Madeline J. Caduc, Martin Zenke, +2 more
3citations -
A Phase 3, Randomized, Double-Blind, Active-Comparator-Controlled Study of Bomedemstat Versus Hydroxyurea in Patients with Essential Thrombocythemia Naïve to Cytoreductive Therapy2024 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Yuka Sugimoto, Eran Zimran, Yoshimitsu Shimomura, Hiroki Yamaguchi, Hans Carl Hasselbach, Jean‐Jacques Kiladjian, +14 more
2citations -
Clonal haematopoiesis of indeterminate potential and impaired kidney function—A Danish general population study with 11 years follow‐up2022 European Journal Of Haematology article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Morten Kranker Larsen, Vibe Skov, Lasse Kjær, Natascha A. Møller‐Palacino, Rasmus Kristoffer Pedersen, Morten Andersen, +14 more
18citations -
The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 study2026 Blood Advances article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Harinder Gill, Abdulraheem Yacoub, Aaron Thomas Gerds, Jake Shortt, James M. Rossetti, Adam J. Mead, +16 more
2citations